119 related articles for article (PubMed ID: 9668313)
1. Specificity of the Lambert-Eaton syndrome antibodies. Downregulation of P/Q-type calcium channels in bovine adrenal chromaffin cells.
Kim YI; Nam TS; Kim SH; Viglione MP; Kim J
Ann N Y Acad Sci; 1998 May; 841():677-83. PubMed ID: 9668313
[No Abstract] [Full Text] [Related]
2. Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.
Engisch KL; Rich MM; Cook N; Nowycky MC
J Neurosci; 1999 May; 19(9):3384-95. PubMed ID: 10212298
[TBL] [Abstract][Full Text] [Related]
3. Lambert-Eaton syndrome IgG inhibits dihydropyridine-sensitive, slowly inactivating calcium channels in bovine adrenal chromaffin cells.
Blandino JK; Kim YI
Ann N Y Acad Sci; 1993 Jun; 681():394-7. PubMed ID: 8395153
[No Abstract] [Full Text] [Related]
4. Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.
Satoh Y; Hirashima N; Tokumaru H; Takahashi MP; Kang J; Viglione MP; Kim YI; Kirino Y
J Physiol; 1998 Apr; 508 ( Pt 2)(Pt 2):427-38. PubMed ID: 9508807
[TBL] [Abstract][Full Text] [Related]
5. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
Waterman SA; Lang B; Newsom-Davis J
Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
[TBL] [Abstract][Full Text] [Related]
6. Specificity of autoantibodies react with omega-conotoxin MVIIC-sensitive calcium channel in Lambert-Eaton myasthenic syndrome.
Suenaga A; Shirabe S; Nakamura T; Motomura M; Tsujihata M; Matsuo H; Kataoka Y; Niwa M; Itoh M; Nagataki S
Muscle Nerve; 1996 Sep; 19(9):1166-8. PubMed ID: 8761275
[No Abstract] [Full Text] [Related]
7. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
Johnston I; Lang B; Leys K; Newsom-Davis J
Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
[TBL] [Abstract][Full Text] [Related]
8. Lambert-Eaton antibodies promote activity-dependent enhancement of exocytosis in bovine adrenal chromaffin cells.
Engisch KL; Rich MM; Cook N; Nowycky MC
Ann N Y Acad Sci; 1999 Apr; 868():213-6. PubMed ID: 10414296
[No Abstract] [Full Text] [Related]
9. Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.
Giovannini F; Sher E; Webster R; Boot J; Lang B
Br J Pharmacol; 2002 Aug; 136(8):1135-45. PubMed ID: 12163346
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of Lambert-Eaton myasthenic syndrome immunoglobulin on cloned neuronal voltage-gated calcium channels.
Pinto A; Moss F; Lang B; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Newsom-Davis J
Ann N Y Acad Sci; 1998 May; 841():687-90. PubMed ID: 9668315
[No Abstract] [Full Text] [Related]
11. Down-regulation of non-L-, non-N-type (Q-like) Ca2+ channels by Lambert-Eaton myasthenic syndrome (LEMS) antibodies in rat insulinoma RINm5F cells.
Magnelli V; Grassi C; Parlatore E; Sher E; Carbone E
FEBS Lett; 1996 May; 387(1):47-52. PubMed ID: 8654565
[TBL] [Abstract][Full Text] [Related]
12. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
[TBL] [Abstract][Full Text] [Related]
13. Adrenal medulla calcium channel population is not conserved in bovine chromaffin cells in culture.
Benavides A; Calvo S; Tornero D; González-García C; Ceña V
Neuroscience; 2004; 128(1):99-109. PubMed ID: 15450357
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A
Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874
[TBL] [Abstract][Full Text] [Related]
15. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
[TBL] [Abstract][Full Text] [Related]
16. Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies.
Sher E; Carbone E; Clementi F
Ann N Y Acad Sci; 1993 Jun; 681():373-81. PubMed ID: 8395151
[No Abstract] [Full Text] [Related]
17. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells.
Viglione MP; O'Shaughnessy TJ; Kim YI
J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):303-17. PubMed ID: 8568672
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody specificities in Lambert-Eaton myasthenic syndrome.
Lang B; Johnston I; Leys K; Elrington G; Marqueze B; Leveque C; Martin-Moutot N; Seagar M; Hoshino T; Takahashi M
Ann N Y Acad Sci; 1993 Jun; 681():382-93. PubMed ID: 8395152
[No Abstract] [Full Text] [Related]
19. Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels.
Spillane J; Ermolyuk Y; Cano-Jaimez M; Lang B; Vincent A; Volynski KE; Kullmann DM
Neurology; 2015 Feb; 84(6):575-9. PubMed ID: 25589670
[TBL] [Abstract][Full Text] [Related]
20. Functional evaluation of inhibition of autonomic transmitter release by autoantibody from Lambert-Eaton myasthenic syndrome.
Houzen H; Hattori Y; Kanno M; Kikuchi S; Tashiro K; Motomura M; Nakao Y; Nakamura T
Ann Neurol; 1998 May; 43(5):677-80. PubMed ID: 9585366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]